Key result
Pretreatment with the ACE inhibitor lisinopril prevented the pressor response to ANG-(1-12) and suppressed ANG II formation in both normotensive and hypertensive rats, whereas chymase inhibition had no effect.
Why the study?
Does ACE or chymase inhibition alter angiotensin peptide formation during ANG-(1-12) infusion in WKY and SHR rats?
Does ACE or chymase inhibition alter angiotensin peptide formation during ANG-(1-12) infusion in WKY and SHR rats?
ACE acts as the primary enzyme for the conversion of ANG-(1-12) to smaller angiotensin peptides in the circulation of WKY and SHR rats.
Answers are grounded in this paper and cite their sources.
ACE inhibition blocks ANG-(1-12) effects in rats; confirms pathway primacy but leaves open human translation.
Angiotensin-(1-12) [ANG-(1-12)], a new member of the renin-angiotensin system, is recognized as a renin independent precursor for ANG II. However, the processing of ANG-(1-12) in the circulation in vivo is not fully established. We examined the effect of angiotensin converting enzyme (ACE) and chymase inhibition on angiotensin peptides formation during an intravenous infusion of ANG-(1-12) in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). WKY and SHR were assigned to a short ANG-(1-12) infusion lasting 5, 15, 30, or 60 min (n = 4-10 each group). In another experiment WKY and SHR were assigned to a continuous 15-min ANG-(1-12) infusion with pretreatment of saline, lisinopril (10 mg/kg), or chymostatin (10 mg/kg) (n = 7-13 each group). Saline or lisinopril were infused intravenously 15 min before the administration of ANG-(1-12) (2 nmol·kg(-1)·min(-1)), whereas chymostatin was given by bolus intraperitoneal injection 30 min before ANG-(1-12). Infusion of ANG-(1-12) increased arterial pressure and plasma ANG-(1-12), ANG I, ANG II, and ANG-(1-7) levels in WKY and SHR. Pretreatment with lisinopril caused increase in ANG-(1-12) and ANG I and large decreases in ANG II compared with the other two groups in both strains. Pretreatment of chymostatin had no effect on ANG-(1-12), ANG I, and ANG II levels in both strains, whereas it increased ANG-(1-7) levels in WKY. We conclude that ACE acts as the primary enzyme for the conversion of ANG-(1-12) to smaller angiotensin peptides in the circulation of WKY and SHR and that chymase may be an ANG-(1-7) degrading enzyme.
No takes yet. Share an insight, caveat, or question.
Moniwa et al. (2013) studied Hypertension (n=91). Lisinopril or Chymostatin vs. Saline was evaluated on Plasma angiotensin peptide concentrations and mean arterial pressure response to ANG-(1-12) infusion. Pretreatment with the ACE inhibitor lisinopril prevented the pressor response to ANG-(1-12) and suppressed ANG II formation in both normotensive and hypertensive rats, whereas chymase inhibition had no effect.
Synapse has enriched 10 related papers. Consider them for comparative context: